Chronic Obstructive Pulmonary Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: COPD diagnosis; absence of cardiovascular diseases; absence of neuromuscular or skeletal reported diseases; absence of contraindications or any impediment to completion of the experimental protocol
Exclusion criteria
Exclusion criteria: Individuals who do not produce at least 95% of sinus beats in the time series of intervals between beats will be deleted consecutive heart used in the analysis of heart rate variability; individuals as you do not complete the protocol experimental and who present clinical instability during the treatent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase of cardiac autonomic modulation afer 24 session of treatment evaluated by changes unless 5% on indices of heart rate variability | — |
Secondary
| Measure | Time frame |
|---|---|
| Increase of cardiopulmonary functional capacity assessed by gain in 30 meters on the 6-minute walk test and increase in peripheral muscle strength assessed by changes unless 5% ondynamometry | — |
Countries
Brazil
Contacts
Universidade Federal de São Paulo